Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Return on Sales (2021 - 2024)

Senti Biosciences has reported Return on Sales over the past 4 years, most recently at 0.64% for Q2 2024.

  • For Q2 2024, Return on Sales rose 71.0% year-over-year to 0.64%; the TTM value through Jun 2024 reached 0.64%, up 70.0%, while the annual FY2025 figure was 30.84%, N/A changed from the prior year.
  • Return on Sales for Q2 2024 was 0.64% at Senti Biosciences, up from 0.17% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.64% in Q3 2023 and troughed at 0.2% in Q2 2022.
  • A 4-year average of 0.1% and a median of 0.04% in 2023 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: tumbled -39bps in 2023 and later surged 71bps in 2024.
  • Year by year, Return on Sales stood at 0.05% in 2021, then skyrocketed by 1020bps to 0.45% in 2022, then plummeted by -88bps to 0.05% in 2023, then surged by 1100bps to 0.64% in 2024.
  • Business Quant data shows Return on Sales for SNTI at 0.64% in Q2 2024, 0.17% in Q1 2024, and 0.05% in Q4 2023.